awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q41740586-150C18DF-250B-4621-A5A8-433DC34D1459
Q41740586-150C18DF-250B-4621-A5A8-433DC34D1459
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41740586-150C18DF-250B-4621-A5A8-433DC34D1459
Intralesional administration of L19-IL2/L19-TNF in stage III or stage IVM1a melanoma patients: results of a phase II study.
P2860
Q41740586-150C18DF-250B-4621-A5A8-433DC34D1459
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41740586-150C18DF-250B-4621-A5A8-433DC34D1459
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e4acc0e9fe76a102cf6ab47c62fc551863161949
P2860
IL-2 administration increases CD4+ CD25(hi) Foxp3+ regulatory T cells in cancer patients.